<?xml version="1.0" encoding="UTF-8"?>
<p>We investigated SOD and GPX activities and the total content of reduced GSH, protein carbonyl, and MDA levels in the brain tissue to determine whether TEO inhibits oxidative damage induced by Sco. Sco treatment resulted in significant decrease in the specific activities of the antioxidants enzymesâ€”SOD (
 <italic>p</italic> &lt; 0.0001) (
 <xref ref-type="fig" rid="antioxidants-09-01083-f005">Figure 5</xref>B), GPX (
 <italic>p</italic> &lt; 0.0001) (
 <xref ref-type="fig" rid="antioxidants-09-01083-f005">Figure 5</xref>C), the total content of reduced GSH (
 <italic>p</italic> &lt; 0.001) (
 <xref ref-type="fig" rid="antioxidants-09-01083-f005">Figure 5</xref>D), along with increased levels of protein carbonyl (
 <italic>p</italic> &lt; 0.01) (
 <xref ref-type="fig" rid="antioxidants-09-01083-f005">Figure 5</xref>E) and lipid peroxidation (MDA) (
 <italic>p</italic> &lt; 0.001) (
 <xref ref-type="fig" rid="antioxidants-09-01083-f005">Figure 5</xref>F) when compared with the control group. Besides, TEO co-administration significantly ameliorated Sco-induced oxidative stress by enhancing the activity of the antioxidant enzymes and suppressing the levels of protein carbonyl and lipid peroxidation relative to Sco-treated animals.
</p>
